Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01744574 · ClinicalTrials.gov registry record · NA
Sex Differences, Hormones & Smoking Cessation
A NA study of Tobacco Cessation, sponsored by University of Minnesota.
- Completed
- Registry status
- NA
- Development phase
- 216
- Enrollment target
- 1
- Study location
NCT01744574: Completed NA study of Tobacco Cessation, sponsored by University of Minnesota.
NCT01744574 is a NA study of Tobacco Cessation that has completed, run by University of Minnesota. The registered enrollment target is 216 participants, below the 1,643-participant average among 8 other Tobacco Cessation trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01744574, a NA study of Tobacco Cessation, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- NA
- Development phase
- 216 participants
- Enrollment target
- 1
- Study location
Study Summary
Data suggest that progesterone may improve smoking cessation outcomes perhaps by reducing impulsive behavior. However, the clinical literature on this topic is lacking. Therefore, in Project I we are proposing a double-blind randomized controlled trial to assess the role of exogenous progesterone on impulsivity and smoking cessation in a sample of males and females who are motivated to quit smoking.
Primary Outcome
7-day point prevalence abstinence from smoking defined as having no slips (i.e., a puff or more from a lit cigarette) in the seven days prior to week 4
Conditions Studied
Interventions
- OTHER Placebo
- DRUG Progesterone
- OTHER Smoking Cessation Behavioral Counseling
Study Locations (1)
Minnesota
- Delaware Clinical Research Unit, University of Minnesota - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 216 participants |
| Start Date | 2012-12 |
| Est. Completion | 2017-07-27 |
| Phase | NA |
What the finished NCT01744574 record still lists
NCT01744574 is an interventional study that assigns participants to a tested intervention. The registered 216 participants enrollment target is mid-sized for trials with a published cap, below the 1,643-participant average among 8 other Tobacco Cessation trials with a reported enrollment target (87% lower).
The record links to 1 condition, with Tobacco Cessation appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT01744574 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT01744574 about?
NCT01744574 is a clinical study titled "Sex Differences, Hormones & Smoking Cessation". Data suggest that progesterone may improve smoking cessation outcomes perhaps by reducing impulsive behavior. However, the clinical literature on this topic is lacking. Therefore, in Project I we are proposing a double-blind randomized controlled trial to assess the role of exogenous progesterone on...
What is the current status of trial NCT01744574?
This trial is currently completed. It is a NA study. The enrollment target is 216 participants. The study started on 2012-12. Estimated completion is 2017-07-27.
What conditions does trial NCT01744574 study?
This clinical trial studies the following conditions: Tobacco Cessation.
What interventions are being tested in trial NCT01744574?
The interventions under investigation include: Placebo (OTHER), Progesterone (DRUG), Smoking Cessation Behavioral Counseling (OTHER).
Who is sponsoring clinical trial NCT01744574?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01744574 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tobacco Cessation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01744574's enrollment target sits among peer trials
216 4th of 8 higher than 5 of 8 other Tobacco Cessation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Tobacco Cessation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
FRESH Delivers: An Innovative Approach to Reducing Tobacco Use Among Rural Smokers
RECRUITING · NA
-
Addressing Tobacco Use Disparities in Rural Older Adults Through an Innovative Mobile Phone Intervention
COMPLETED · NA
-
P60 Program Project Grant-Outreach for Smoke-Free Homes
COMPLETED · NA
-
Support Person Intervention to Promote a Smoking Helpline
COMPLETED · NA
-
Adolescent Smoking Cessation in Pediatric Primary Care
COMPLETED · NA
-
Neural Mechanisms Connecting Deficient Sleep and Smoking Relapse
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02609685 · 216 participants · NA
Active Surveillance of Papillary Thyroid Microcarcinoma
- NCT04994873 · 216 participants · NA
Skills to Enhance Positivity in Suicidal Youth
- NCT05264779 · 216 participants · NA
The Periviable GOALS Decision Support Tool
- NCT05434130 · 216 participants · Phase 2
Modulating Exercise Dosage to Improve Concussion Recovery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia